Genome Wide Association Studies (gwas) - Pharma

Relevant Publications

Genome-wide association studies of lifetime and frequency cannabis use in 131,895 individuals.

Issue Release: 2024

Immune-mediated inflammatory diseases and periodontal disease: a bidirectional two-sample mendelian randomization study.

Issue Release: 2024

Causal relationship between multiple sclerosis and cortical structure: a Mendelian randomization study.

Issue Release: 2024

The Gene Expression Landscape of Disease Genes.

Issue Release: 2024

Proteome-wide association studies have predicted that the protein abundance of LSM6, GMPPB, ICA1L, and CISD2 is associated with attention-deficit/hyperactivity disorder.

Issue Release: 2024

Revealing brain cell-stratified causality through dissecting causal variants according to their cell-type-specific effects on gene expression.

Issue Release: 2024

Association of cancer and schizophrenia, major depression and bipolar disorder: A Mendelian randomization study.

Issue Release: 2024

Circadian clock gene polymorphisms implicated in human pathologies.

Issue Release: 2024

Mendelian randomization study on association between grip strength and BMD in different age groups.

Issue Release: 2024

Legal aspects of privacy-enhancing technologies in genome-wide association studies and their impact on performance and feasibility.

Issue Release: 2024

NSAID medication mediates the causal effect of genetically predicted major depressive disorder on falls: Evidence from a Mendelian randomization study.

Issue Release: 2024

Genome-wide association study revealed significant SNPs for anthracnose resistance, seed alkaloids and protein content in white lupin.

Issue Release: 2024

Unveiling new genetic insights in rheumatoid arthritis for drug discovery through Taxonomy3 analysis.

Issue Release: 2024

Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome.

Issue Release: 2024

Using Alternative Definitions of Controls to Increase Statistical Power in GWAS.

Issue Release: 2024

Schizophrenia and risk preference: a bidirectional two-sample mendelian randomization study.

Issue Release: 2024

Plasma proteins and inflammatory dermatoses: proteome-wide Mendelian randomization and colocalization analyses.

Issue Release: 2024

High bioavailable testosterone levels increase the incidence of isolated REM sleep behavior disorder: Results from multivariable and network Mendelian randomization analysis.

Issue Release: 2024

Association of circulating minerals and vitamins with pregnancy complications: a Mendelian randomization study.

Issue Release: 2024

The causal effect of atopic dermatitis on lung cancer: A Mendelian randomization study.

Issue Release: 2024

What is the Future of ADE Management?

What Role Does Technology Play?

How Can ADEs be Prevented?

What are the Phases of Clinical Trials?

What is Regulatory Approval?

Why are Collaborative Care Models Important in Pharma?

Why is the Management of Chronic Conditions Important?

What is Transitional Care?

What are the Regulatory Requirements for Generic Drugs?

Why is Medication Management Important?

Partnered Content Networks

Relevant Topics